Garmin celebrates global digital health innovation at 2026 Garmin Health Summit in Asia

Garmin (NYSE: GRMN) announced the recipients of its 2026 Garmin Health Awards at the conclusion of its annual summit in Bangkok.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Positive)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Garmin (NYSE: GRMN) announced the recipients of its 2026 Garmin Health Awards at the conclusion of its annual summit in Bangkok. Montefiore Einstein received Expert's Choice for its use of Garmin's wearable-data ecosystem in prospective cancer-treatment trials. HeraMED received People's Choice for its women's health platform.

Finalists were selected from 113 applications across 31 countries. Each winner received Garmin smartwatches and fitness trackers worth up to $10,000. The summit's second day brought together over 200 executives and industry leaders, with presentations covering wearable integration and research.

Key Figures

Award value: Up to $10,000

Award value: Up to $10,000; Smartwatches and fitness trackers awarded to each winner

Key Terms

api, sdks, radiotherapy, chemotherapy, +1 more

5 terms

api technical

"the Garmin Health API and SDKs"

An API, or Application Programming Interface, is a set of rules that allows different software programs to communicate and work together smoothly, much like a waiter translating your order into the kitchen and then bringing your meal back. For investors, APIs are important because they enable real-time access to financial data, trading systems, and other digital services, making it easier to make informed decisions quickly and efficiently.

sdks technical

"the Garmin Health API and SDKs"

Software Development Kits (SDKs) are bundles of tools, code samples and instructions that let other developers add a company’s technology to their own apps or devices, like giving builders a prefabricated toolbox. For investors, SDKs matter because they help spread a product’s use faster, lower integration costs for partners, and can drive recurring revenue or user growth—signals that a technology is gaining market traction.

radiotherapy medical

"patients with cancer receiving radiotherapy, chemotherapy, and immunotherapy"

Radiotherapy is a medical treatment that uses targeted high-energy radiation to shrink or destroy tumors and control disease, similar to using a focused beam to remove weeds without digging up the whole garden. It matters to investors because approvals, new technologies, clinical trial results, or changes in treatment guidelines can affect demand for equipment, drug combinations, and patient outcomes, which in turn influence revenue and growth prospects for healthcare companies.

chemotherapy medical

"patients with cancer receiving radiotherapy, chemotherapy, and immunotherapy"

Chemotherapy is the use of drugs to kill or slow the growth of cancer cells, typically given as pills or intravenous infusions; because these drugs target rapidly dividing cells they can also harm healthy tissue and cause side effects. It matters to investors because clinical trial results, regulatory approvals, pricing and insurance coverage directly affect a drugmaker’s sales, hospital treatment patterns and overall healthcare spending—much like a new product that can change a company’s market share.

immunotherapy medical

"patients with cancer receiving radiotherapy, chemotherapy, and immunotherapy"

Treatment that uses or enhances the body’s immune system to detect and fight disease, most often cancers or chronic infections; think of it as training or arming the body’s own soldiers to find and destroy targets. It matters to investors because successful immunotherapies can lead to high-value drug approvals, recurring revenue from long-term treatments, and changes in competitive dynamics, while failures or safety issues in clinical trials can materially affect company valuations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

10/29/2026 - 09:02 AM EDT

Annual event recognizes top health solutions, bringing together industry leaders from around the world

OLATHE, Kan., Oct. 29, 2026 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced the recipients of the 2026 Garmin Health Awards, recognizing groundbreaking digital health solutions. Presented at the conclusion of the annual Garmin Health Summit in Bangkok, the awards honor innovators who successfully utilize the Garmin Health Connected Ecosystem (GHCE), which includes Garmin wearables and the Garmin Health API and SDKs, to improve health outcomes.

Annual event recognizes top health solutions, bringing together industry leaders from around the world.

"As high-quality data from wearables becomes increasingly important for personalized feedback and customizable approaches to health and wellness, our Awards applicants, finalists and winners continue to showcase incredible thought leadership and vision as they reimagine industries like research, healthcare, insurance and many others. Thank you to everyone who joined us at this year's Summit and made it such an impactful and inspiring event."
–Susan Lyman, Garmin Vice President of Consumer Sales and Marketing

Here are the 2026 Garmin Health Awards honorees:

Expert's Choice – Montefiore Einstein, a U.S.-based cancer center, leveraged the GHCE in prospective trials for patients with cancer receiving radiotherapy, chemotherapy, and immunotherapy, demonstrating the feasibility of monitoring daily activity with wearables. Its researchers were the first to show data from wearables can be collected passively before treatment to identify patients likely to struggle with therapy.

People's Choice – HeraMED is an Australian publicly listed company transforming women's health through personalized, continuous, AI-enabled care—empowering women across pregnancy, postpartum, menopause, and chronic conditions within a unified, scalable, data-driven platform.

Garmin Health Awards background information

This year's finalists, selected from 113 applications spanning 31 countries, presented their solutions to two different panels of judges – one made up of industry experts and the other of Summit attendees. Each submission was evaluated on customer benefit, scalability, uniqueness, innovation and performance, as well as how they aligned with the Garmin Health key areas of focus: healthcare and research, insurance and employee well-being, and fitness and wellness.

Expert's Choice and People's Choice winners each received Garmin smartwatches and fitness trackers worth up to $10,000.

Exclusive announcements and updates

Held this year in Bangkok, Thailand, the Garmin Health Summit began with an invite-only media event attended by journalists focused on digital health and wearable technology. The program featured Garmin executive remarks, business insights, real-life examples of wearable integration and preliminary research findings.

Garmin Health business insights: Joern Watzke, Senior Director of Garmin Health Global Sales, shared details about business development in Asia and around the world, providing an interesting look into which industries and countries are adopting wearable data integration the fastest.
Longevity metrics and use cases: Scott Burgett, Senior Director of Garmin Health Engineering, presented on Garmin biometrics used to evaluate longevity and healthspan, while panelists from around the world discussed approaches to longevity support and what preventive care and policies might look like in the future.
Exclusive research findings from Professor Francesco Pagnini: Through his work with the European Space Agency (ESA) and Italian Navy, Prof. Dr. Pagnini has utilized data from Garmin wearables¹to evaluate the mind-body connection in extreme environments. He shared preliminary findings from current research projects.

Keynote and expert presentations

The second day of the Garmin Health Summit brought together over 200 executives and industry leaders to learn, connect and share thoughts about the future of wearable integration into business sectors like healthcare, insurance, employee benefits, fitness and more.

Keynote with Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals: In her keynote, "From Hospitals to Everywhere: Reimagining Care with AI and Technology," Dr. Reddy shared her perspective on digital health and how technology can help improve access to care for underserved communities.
Expert Presentations: Jaemy Park of Thyroscope discussed using sleep heart rate as a digital biomarker for thyroid care; Dr. Amy Elliott, Chief Clinical Research Officer at Avera Research Institute, and Dr. Christa Friedrich, Director of Research Operations at Avera Research Institute, presented "From Wrist to Outcomes: Integrating Garmin Wearables into the NIH ECHO Study Across Pregnancy and Childhood"; and Dylan Hartley of WHG Solutions discussed fatigue monitoring and management for truck drivers.

Held each year in a different city – with previous locations including New York City, Prague and Singapore – the Garmin Health Summit offers a unique opportunity for global Garmin Health collaborators to engage in valuable networking and learning opportunities. To learn more, visit the Garmin Health Summit webpage.

Garmin Health empowers innovative third-party digital health solutions with the Garmin Health Connected Ecosystem, comprised of the Garmin product portfolio and its data integration services. By leveraging the Garmin Health API and SDKs, organizations can receive real-time or existing biometric data – with customizable levels of granularity – in accordance with their specific privacy policies. Garmin Health is a globally focused division of technology leader Garmin, collaborating with entities in areas like healthcare, research, employee benefits, insurance, fitness and defense. For more information, email our media team, connect with us on LinkedIn or visit us online at garmin.com/health.

¹Garmin wearables are consumer wellness devices and are not medical devices intended to diagnose, treat, prevent or monitor medical conditions. Any medical or clinical functionality described is provided by a third-party solution, based solely on the third party's interpretation of data collected by its applications through the Garmin Health Connected Ecosystem or third-party sources.

About Garmin International, Inc. Garmin International, Inc. is a subsidiary of Garmin Ltd. (NYSE: GRMN). Garmin Ltd. is incorporated in Switzerland, and its principal subsidiaries are located in the United States, Taiwan and the United Kingdom. Garmin is a registered trademark of Garmin Ltd. or its subsidiaries.

Notice on Forward-Looking Statements:
This release includes forward-looking statements regarding Garmin Ltd. and its business. Such statements are based on management's current expectations. The forward-looking events and circumstances discussed in this release may not occur and actual results could differ materially as a result of known and unknown risk factors and uncertainties affecting Garmin, including, but not limited to, the risk factors listed in the Annual Report on Form 10-K for the year ended December 27, 2025, filed by Garmin with the Securities and Exchange Commission (Commission file number 0-31983). Copies of such Form 10-K are available at https://www.garmin.com/en-US/investors/sec/. No forward-looking statement can be guaranteed. Forward-looking statements speak only as of the date on which they are made and Garmin undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

MEDIA CONTACTS:
Elliott Scott
913-397-8200
media.relations@garmin.com